BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wagner V, Minguez-menendez A, Pena J, Fernández-prada C. Innovative Solutions for the Control of Leishmaniases: Nanoscale Drug Delivery Systems. CPD 2019;25:1582-92. [DOI: 10.2174/1381612825666190621154552] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Oliveira SSC, Marques CSF, de Sousa DP, Andrade LN, Fricks AT, Jain S, Branquinha MH, Souto EB, Santos ALS, Severino P. Analysis of the mechanisms of action of isopentenyl caffeate against Leishmania. Biochimie 2021;189:158-67. [PMID: 34216704 DOI: 10.1016/j.biochi.2021.06.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kammona O, Tsanaktsidou E. Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis. Int J Pharm 2021;605:120761. [PMID: 34081999 DOI: 10.1016/j.ijpharm.2021.120761] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Jafari M, Abolmaali SS, Tamaddon AM, Zomorodian K, Sarkari BS. Nanotechnology approaches for delivery and targeting of Amphotericin B in fungal and parasitic diseases. Nanomedicine (Lond) 2021;16:857-77. [PMID: 33890492 DOI: 10.2217/nnm-2020-0482] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Dong G, Wagner V, Minguez-Menendez A, Fernandez-Prada C, Olivier M. Extracellular vesicles and leishmaniasis: Current knowledge and promising avenues for future development. Mol Immunol 2021;135:73-83. [PMID: 33873096 DOI: 10.1016/j.molimm.2021.04.003] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Andrade RGD, Reis B, Costas B, Lima SAC, Reis S. Modulation of Macrophages M1/M2 Polarization Using Carbohydrate-Functionalized Polymeric Nanoparticles. Polymers (Basel) 2020;13:E88. [PMID: 33379389 DOI: 10.3390/polym13010088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
6 Freitas CS, Oliveira-da-Silva JA, Lage DP, Costa RR, Mendonça DVC, Martins VT, Reis TAR, Antinarelli LMR, Machado AS, Tavares GSV, Ramos FF, Coelho VTS, Brito RCF, Ludolf F, Chávez-Fumagalli MA, Roatt BM, Ramos GS, Munkert J, Ottoni FM, Campana PRV, Humbert MV, Coimbra ES, Braga FC, Pádua RM, Coelho EAF. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitol Res 2021;120:321-35. [PMID: 33191446 DOI: 10.1007/s00436-020-06971-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Roatt BM, de Oliveira Cardoso JM, De Brito RCF, Coura-Vital W, de Oliveira Aguiar-Soares RD, Reis AB. Recent advances and new strategies on leishmaniasis treatment. Appl Microbiol Biotechnol 2020;104:8965-77. [PMID: 32875362 DOI: 10.1007/s00253-020-10856-w] [Cited by in Crossref: 16] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
8 Pereira IAG, Mendonça DVC, Tavares GSV, Lage DP, Ramos FF, Oliveira-da-Silva JA, Antinarelli LMR, Machado AS, Carvalho LM, Carvalho AMRS, Salustiano IV, Reis TAR, Bandeira RS, Silva AM, Martins VT, Chávez-Fumagalli MA, Humbert MV, Roatt BM, Duarte MC, Menezes-Souza D, Coimbra ES, Leite JPV, Coelho EAF, Gonçalves DU. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis. Parasite Immunol 2020;42:e12784. [PMID: 32772379 DOI: 10.1111/pim.12784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Castellano LRC, Bonan PRF, Medeiros ES. Nanoscaled Drug Delivery Systems Applied to Parasitic Diseases. Curr Pharm Des 2019;25:1581. [PMID: 31470775 DOI: 10.2174/138161282514190816143633] [Reference Citation Analysis]